Press Release 23 Apr 2012

Dublin, 23rd April  2012 -
Minister for Jobs, Enterprise and Innovation Richard Bruton TD today announced that Diaceutics, an international business consulting and software application firm specializing in personalized medicine, is to create 20 new jobs over 3 years, with the support of Government through IDA Ireland.

These new positions will be located in the incubation centre in Dundalk Institute of Technology and will focus on the further development of Diaceutics Fusion Ô a proprietary web-based software application that provides a range of business intelligence and performance management applications used for personalised medicine planning, collaboration and decision-making for the global pharmaceutical sector.  Recruitment will begin immediately for IT professionals and industry analysts.
Diaceutics focus in Dundalk will be based on the further development, support and sale of the Diaceutics Fusion software. Personalized medicine utilizes genetic, molecular and other diagnostic tests to identify groups of patients for whom specific drugs are most effective and safest, and is a rapidly growing market expected to double in value by 2015.
Making the announcement Minister Bruton said: "Today's announcement that Diaceutics is locating in Ireland, creating 20 jobs is excellent news. A key part of the Government’s plan for jobs and growth is ensuring that we deepen and develop the impact of multinational investment here. We have a base of multinational companies here that is the envy of the world, but if we are to create the numbers of jobs we need we must build on this and attract a new cohort of companies which we haven’t reached before.

“Today’s announcement that five high-growth early-stage European companies are locating operations in Ireland with the creation of 77 jobs is great news. These are companies that might be relatively small now, but have the potential to grow exponentially and create large numbers of jobs here. Through continued implementation of the Action Plan for Jobs I am determined to ensure that we attract a wider spread of multinational companies and help get Ireland back to work”.

“Rapid growth and development of new services and software products requires a full-time team not only with experience in the IT sector but with a collaborative and innovative environment, which is ably provided by the incubation center at Dundalk Institute of Technology,” said Ryan Keeling, SVP, IT Solutions, Diaceutics.
Commenting on the announcement Barry O’Leary, CEO IDA Ireland said “Health informatics is an emerging area of importance in the Life Sciences area and as such, the addition of Diaceutics to a growing hub of companies operating in the personalised medicines space, is most welcome. Part of IDA Ireland’s Strategy – Horizon 2020 – is to encourage early stage and internationally traded services sectors to locate and invest in Ireland. Diaceutics decision to set up a strategically important part of its business in Dundalk, is an endorsement of IDA’s ability to attract emerging multinational businesses to internationalise from Ireland.”
About Diaceutics:
Diaceutics is the leading provider of personalized medicine consulting, software and service solutions, helping the pharmaceutical, diagnostic and laboratory industry standardize the planning, analytical and action steps needed for the successful development, commercialization and launch of targeted therapies. Our proven process has been used by 12 of the top pharmaceutical companies worldwide, on over 25 targeted therapy assets, delivering repeatable results and superior returns on investment.
For further information contact:
Diaceutics – Ryan Keeling, SVP, IT Solutions, +353 (0)42 9370481, Email

Contact us

Contact IDA Ireland

You'll find us responsive to your needs, proactive, professional and willing to go the extra mile.

Contact IDA Ireland

International Offices

We have 28 Offices worldwide helping support companies expand their operations in Ireland.

Find your nearest office